Page last updated: 2024-10-29

imipramine and Meningeal Neoplasms

imipramine has been researched along with Meningeal Neoplasms in 1 studies

Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.

Meningeal Neoplasms: Benign and malignant neoplastic processes that arise from or secondarily involve the meningeal coverings of the brain and spinal cord.

Research Excerpts

ExcerptRelevanceReference
"Imipramine (IMI) treatment yielded complete remission of her symptoms for three years."1.29Panic attacks, complex partial seizures, and multiple meningiomas. ( Nickell, PV, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nickell, PV1

Other Studies

1 other study available for imipramine and Meningeal Neoplasms

ArticleYear
Panic attacks, complex partial seizures, and multiple meningiomas.
    Anxiety, 1994, Volume: 1, Issue:1

    Topics: Adult; Antidepressive Agents, Tricyclic; Cerebral Ventricles; Epilepsy, Complex Partial; Female; Hip

1994